NCT04567849 is a NA clinical trial of message in Emergency Treatment, sponsored by Geisinger Clinic.

Who is sponsoring NCT04567849?

NCT04567849 is sponsored by Geisinger Clinic.

What drugs are being tested in NCT04567849?

Interventions in NCT04567849: message, provider, tele-nurse.

What condition does NCT04567849 study?

NCT04567849 studies Emergency Treatment, Telephone Hotlines.

Is NCT04567849 still recruiting?

NCT04567849 is currently completed. Last updated 18 July 2023.

Last reviewed 2023-07-18 · How we verify

NCT04567849

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Decreasing ED Utilization by Nudging Patients to Call Their Providers

Completed NA Last updated 18 July 2023

What this trial tests

NA trial testing message in Emergency Treatment in 11,546 participants. Completed in 15 June 2023.

Timeline

16 November 2021

Primary endpoint
15 June 2023

15 June 2023

Quick facts

Lead sponsor	Geisinger Clinic
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	health services research
Enrollment	11,546
Start date	16 November 2021
Primary completion	15 June 2023
Estimated completion	15 June 2023
Sites	1 location across United States

Drugs / interventions tested

message
provider
tele-nurse

Conditions studied

Emergency Treatment — all drugs for Emergency Treatment →
Telephone Hotlines — all drugs for Telephone Hotlines →

Sponsor

Geisinger Clinic

Who can join

Eligibility, any sex, with Emergency Treatment or Telephone Hotlines. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the present study, patients will be sent a message shortly after completing a medical procedure that informs or reminds them that they can reach out to Geisinger, and how to do it, if they have any medical issues or concerns. Researchers will assess if such messages make patients more likely to contact Geisinger with post-procedure medical concerns and decrease emergency department utilization.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Emergency Treatment

Currently open trials in the same condition.

NCT06602856 — Point-of-care-ultrasound in Swiss Air Rescue Rega · recruiting

Other Geisinger Clinic trials

Trials by the same sponsor.

NCT07197801 — Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Diso · NA · recruiting
NCT06936709 — Perioperative Colchicine for TKA · Phase 4 · not yet recruiting
NCT07042477 — Integrated Telemedicine Program Evaluation · NA · recruiting
NCT07028398 — CMSL Ambulatory Sensitive Condition Nudge Study 2 · NA · recruiting
NCT06696066 — PEERS Pilot: Peer Recovery Support Program to Support Engagement in Medication for Opioid Use Disorder · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04567849 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Geisinger Clinic
Last refreshed: 18 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04567849.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing